Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?

BACKGROUND: The benefit of adjuvant immunotherapy after nephrectomy in renal cell carcinoma (RCC) is controversial. The present study aimed to examine the possible benefit of adjuvant immunotherapy in various clinical settings. METHODS: We retrospectively reviewed 436 patients with pT1-3N0-2M0 RCC w...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Taguchi, Satoru, Buti, Sebastiano, Fukuhara, Hiroshi, Otsuka, Masafumi, Bersanelli, Melissa, Morikawa, Teppei, Miyazaki, Hideyo, Nakagawa, Tohru, Fujimura, Tetsuya, Kume, Haruki, Igawa, Yasuhiko, Homma, Yukio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5328261/
https://ncbi.nlm.nih.gov/pubmed/28241027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0172341
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia